Specialized Migraine Treatment Solutions for Unique Environments
Legal Citation
Summary of the Inventive Concept
The present disclosure relates to specialized medicaments and methods for treating migraine in unique operational environments, such as high-altitude, air travel, remote wilderness, high-security, and disaster relief settings.
Background and Problem Solved
The original patent addressed the unmet need for effective treatments of migraine with or without aura. However, it did not consider the specific challenges posed by treating migraine in unique operational environments. The present inventive concept adapts the original patent's approach to address these specific challenges, ensuring effective treatment in diverse settings.
Detailed Description of the Inventive Concept
The inventive concept comprises specialized systems, methods, and kits for treating migraine in unique operational environments. For example, the system for treating migraine in a high-altitude environment includes a portable storage unit containing a predetermined quantity of ubrogepant, designed to operate at elevations above 8,000 feet. Similarly, the method for treating migraine in a patient undergoing air travel involves orally administering 50 mg of ubrogepant to the patient prior to takeoff, ensuring alleviation of migraine symptoms during the flight. Other embodiments include kits for treating migraine in remote wilderness settings and systems for treating migraine in high-security environments.
Novelty and Inventive Step
The inventive concept's novelty lies in its adaptation of the original patent's approach to address the specific challenges posed by unique operational environments. The inventive step resides in the recognition of the need for specialized solutions and the development of systems, methods, and kits that effectively treat migraine in these environments.
Alternative Embodiments and Variations
Alternative embodiments may include systems and methods for treating migraine in other unique environments, such as space travel or extreme weather conditions. Variations may also include different dosing regimens or formulations of ubrogepant tailored to specific environments.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the pharmaceutical industry, particularly in the areas of migraine treatment and emergency response. Target industries may include aerospace, defense, and disaster relief organizations, as well as remote wilderness adventure and tourism operators.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical treatment of neurological conditions, specifically migraine management, with expertise in drug dosing, patient-specific administration, and specialized medical interventions
Person of Ordinary Skill (PHOSITA) Profile
A medical researcher or clinical pharmacologist with advanced training in neuropharmacology, experienced in developing targeted drug delivery solutions for complex medical conditions, familiar with patient-specific dosing adaptations
Obviousness Rationale
A PHOSITA would recognize that the core ubrogepant treatment method from the source patent can be readily adapted to unique environmental contexts by applying standard pharmaceutical engineering principles. The fundamental pharmacological mechanism remains consistent across different operational scenarios. The variations represent predictable extensions of the original treatment approach, utilizing known drug administration techniques.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,542 |
|---|---|
| Title | Treatment of migraine |
| Assignee(s) | Allergan Pharmaceuticals International Limited |